Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects With Axillary Hyperhidrosis
Conditions
Interventions
Sofpironium Bromide Gel, 15%
Vehicle
Locations
39
United States
Total Skin and Beauty Dermatology Center, P.C.
Birmingham, Alabama, United States
Investigate MD, LLC
Scottsdale, Arizona, United States
Northwest Arkansas Clinical Trials Center
Rogers, Arkansas, United States
California Dermatology & Clinical Research Institute
Encinitas, California, United States
Dermatology Research Associates
Los Angeles, California, United States
Therapeutics Clinical Research
San Diego, California, United States
Start Date
October 9, 2020
Primary Completion Date
June 25, 2021
Completion Date
June 25, 2021
Last Updated
June 6, 2024
NCT04159610
NCT03658616
NCT03785587
NCT03320096
NCT02286765
NCT01091129
Lead Sponsor
Botanix Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions